Results 301 to 308 of about 59,758 (308)
Some of the next articles are maybe not open access.
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Nature Medicine, 2018Yuting Sun +2 more
exaly
Antifungal agents and efflux pump inhibitors.
IDrugs : the investigational drugs journal, 2005S, Arikan, J F, Barrett
openaire +1 more source
The evolving landscape of tissue‐agnostic therapies in precision oncology
Ca-A Cancer Journal for CliniciansVivek Subbiah +2 more
exaly
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
Nature Reviews Cancer, 2008Ludger Hengst, Joyce M Slingerland
exaly
Monitoring immune-checkpoint blockade: response evaluation and biomarker development
Nature Reviews Clinical Oncology, 2017Mizuki Nishino +2 more
exaly
The microbial carbon pump and climate change
Nature Reviews MicrobiologyNianzhi Jiao, , Xilin Xiao
exaly
SWITCH TO AROMATASE INHIBITOR BETTER THAN CONTINUING TAMOXIFEN
Ca-A Cancer Journal for Clinicians, 2005exaly